These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4276374)

  • 41. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
    Breese GR; Cooper BR; Mueller RA
    Br J Pharmacol; 1974 Oct; 52(2):307-314. PubMed ID: 4155993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
    Quock RM; Horita A
    Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of dietary tyrosine on L-dopa- and amphetamine-induced changes in locomotor activity and neurochemistry in mice.
    Thurmond JB; Freeman GB; Soblosky JS; Ieni JR; Brown JW
    Pharmacol Biochem Behav; 1990 Oct; 37(2):259-66. PubMed ID: 2080188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin.
    Ernst AM
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):219-25. PubMed ID: 4262736
    [No Abstract]   [Full Text] [Related]  

  • 45. Behavioral effects of serotonergic and dopaminergic drugs in cats following chronic amphetamine administration.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1984 Apr; 99(4):313-24. PubMed ID: 6734730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of adenine-induced depression of mouse locomotor activity by amphetamine.
    Akintonwa A; Auditore JV
    Arch Int Pharmacodyn Ther; 1978 Oct; 235(2):248-53. PubMed ID: 736702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of a high dose of benserazide on the concentrations of 5-hydroxytryptamine, noradrenaline and dopamine in different regions of the rat brain.
    Vellucci SV
    Gen Pharmacol; 1978; 9(6):451-3. PubMed ID: 153258
    [No Abstract]   [Full Text] [Related]  

  • 50. Behavioral aspects of serotonin-dopamine interaction in the monkey.
    Korsgaard S; Gerlach J; Christensson E
    Eur J Pharmacol; 1985 Dec; 118(3):245-52. PubMed ID: 4085556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of dopamine and serotonin in the prolongation of post-decapitation convulsions in mice.
    Thut PD; Myslinski NR
    Life Sci; 1976 Nov; 19(10):1569-78. PubMed ID: 186673
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of DA in the stimulant effect of DITA in mice; comparison with d-amphetamine.
    Abdallah AH; Roby DM; Boeckler WH; Riley CC
    Eur J Pharmacol; 1976 Jan; 35(1):29-34. PubMed ID: 1253826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of L-5-hydroxytryptophan (5-HTP) on locomotor activity in mice.
    Maj J; Pawlowski
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):145-9. PubMed ID: 1082126
    [No Abstract]   [Full Text] [Related]  

  • 55. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 56. The hypothermic effect of L-dopa in the rat.
    Maj J; Pawlowksi L
    Life Sci; 1973 Jul; 13(2):141-9. PubMed ID: 4270866
    [No Abstract]   [Full Text] [Related]  

  • 57. Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats.
    Maisonneuve IM; Keller RW; Glick SD
    Brain Res; 1992 May; 579(1):87-92. PubMed ID: 1623410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonergic involvement in behavioural responses to amphetamine at high dosage.
    Lees AJ; Fernando JC; Curzon G
    Neuropharmacology; 1979 Feb; 18(2):153-8. PubMed ID: 431782
    [No Abstract]   [Full Text] [Related]  

  • 59. On the mechanism of amphetamine-induced behavioural changes in the mouse. I. An observational analysis of dexamphetamine.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(5):827-33. PubMed ID: 581964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of 5-hydroxytryptamine in the cortical synchronization induced by L-DOPA in the rabbit.
    Gaillard JM; Bartholini G; Herkert B; Tissot R
    Brain Res; 1974 Mar; 68(2):344-50. PubMed ID: 4275029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.